User profiles for K. Boucher

Kenneth M Boucher

- Verified email at hci.utah.edu - Cited by 12610

Kathryn L. Boucher

- Verified email at uindy.edu - Cited by 1015

[HTML][HTML] Can I work with and help others in this field? How communal goals influence interest and participation in STEM fields

KL Boucher, MA Fuesting, AB Diekman… - Frontiers in …, 2017 - frontiersin.org
Although science, technology, engineering, and mathematics (STEM) disciplines as a whole
have made advances in gender parity and greater inclusion for women, these increases …

Eating patterns and risk of colon cancer

ML Slattery, KM Boucher, BJ Caan… - American journal of …, 1998 - academic.oup.com
Colon cancer has been associated with several nutrients and foods. The authors used data
from a population-based study conducted in Northern California, Utah, and Minnesota to …

HLA GENE AND HAPLOTYPE FREQUENCIES IN THE NORTH AMERICAN POPULATION: The National Marrow Donor Program Donor Registry: 1

M Mori, PG Beatty, M Graves, KM Boucher… - …, 1997 - journals.lww.com
… as homozygous; n is the total number of individuals in the sample; and k is the number of
alleles at a locus. This chi-square statistic has k(k-1)/2 degrees of freedom. Note that the test …

[PDF][PDF] Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression

…, AE Folias, A Liou, GE Kim, S Akira, KM Boucher… - Cancer cell, 2011 - cell.com
… (H–K) Amylase. Stat3-deficient mice retained larger areas of amylase-expressing epithelium…
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-…

Metabolic complications with the use of mTOR inhibitors for cancer therapy

…, N Agarwal, B Gartrell, J Ying, KM Boucher… - Cancer treatment …, 2014 - Elsevier
Background mTOR inhibitors are now approved by regulatory agencies for the treatment of
a variety of malignancies. The risk of metabolic complications with these agents is not well …

Characteristics of missed or interval colorectal cancer and patient survival: a population-based study

…, K Curtin, TMF Tuohy, L Pappas, K Boucher… - Gastroenterology, 2014 - Elsevier
Background & Aims Colorectal cancers (CRCs) diagnosed within a few years after an index
colonoscopy can arise from missed lesions or the development of a new tumor. We …

[HTML][HTML] PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers

…, D Wall, MÁ Seguí, L Barley, KM Boucher… - BMC medical …, 2012 - Springer
Background Many methodologies have been used in research to identify the “intrinsic”
subtypes of breast cancer commonly known as Luminal A, Luminal B, HER2-Enriched (HER2-E) …

[HTML][HTML] Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework

…, RL Nussbaum, SA Prabhu, KM Boucher… - Genetics in …, 2018 - Elsevier
Purpose We evaluated the American College of Medical Genetics and Genomics/Association
for Molecular Pathology (ACMG/AMP) variant pathogenicity guidelines for internal …

Microsatellites as EWS/FLI response elements in Ewing's sarcoma

…, AA Shah, KM Boucher… - Proceedings of the …, 2008 - National Acad Sciences
The ETS gene family is frequently involved in chromosome translocations that cause human
cancer, including prostate cancer, leukemia, and sarcoma. However, the mechanisms by …

Clinical germline genetic testing for melanoma.

CB Hansen, LM Wadge, K Lowstuter, K Boucher… - The Lancet …, 2004 - thelancet.com
Clinical genetic testing for mutations in CDKN2A (cyclindependent kinase inhibitor 2A), a
melanoma susceptibility gene, is now available. The International Melanoma Genetics …